Active macromolecule uptake by lymph node antigen-presenting cells: A novel mechanism in determining sentinel lymph node status

Annals of Surgical Oncology

Volumn 7, Issue 2, 2000, Pages 98-105

  Faries, Mark B ^a   Bedrosian, Isabelle ^a   Reynolds, Carol ^b   Nguyen, Hung Q ^a   Alavi, Abass ^a   Czerniecki, Brian J ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b MAYO CLINIC   (United States)

^c HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

99m Technetium sulfur colloid; Antigen uptake; Sentinel lymph node 99mTechnetium human serum albumin

Indexed keywords

ANTIGEN; CELL SURFACE MARKER; FLUORESCEIN ISOTHIOCYANATE; HUMAN SERUM ALBUMIN TC 99M; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TECHNETIUM SULFUR COLLOID TC 99M; TRACER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN PRESENTING CELL; ARTICLE; BIOPSY TECHNIQUE; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; INTERMETHOD COMPARISON; LEUKOCYTE; LYMPH NODE BIOPSY; MACROMOLECULE; NONHUMAN; PARTICLE SIZE; RADIOACTIVITY;

EID: 0034068201     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10434-000-0098-6     Document Type: Article

References (24)

1. Morton DL, Wen DR, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127:392-9.
2. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997;15:2345-50.
3. Krag D, Weaver D, Ashikaga T. The sentinel node in breast cancer. N Engl J Med 1998;339:941-6.
4. Morton DL, Bostick PJ. Will the true sentinel node please stand. Ann Surg Oncol 1999;6:12-4.
5. Kapteijn BAE, Nieweg OE, Muller SH, et al. Validation of gamma probe detection of the sentinel node in melanoma. J Nucl Med 1997;38:362-6.
6. Gershenwald JE, Tseng C, Thompson W, et al. Improved sentinel lymph node localization in patients with primary melanoma with the use of radiolabeled colloid. Surgery 1998;124:204-10.
7. Albertini JJ, Cruse CW, Rapaport D, et al. Intraoperative radiolymphoscintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996;223:217-24.
8. Strand S, Persson BRR. Quantitative lymphoscintigraphy. I. Basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits. J Nucl Med 1979;20:1038-46.
9. Bergqvist L, Strand S, Persson BRR. Particle sizing and biokinetics of interstitial lymphoscintigraphic agents. Semin Nucl Med 1983;13:9-19.
10. Nathanson DS, Anaya P, Karvelis KC, Eck L, Havstad S. Sentinel lymph node uptake of two different technetium-labeled radiocolloids. Ann Surg Oncol 1997;4:104-10.
11. Wong JH, Terada K, Ko P, Coel MN. Lack of effect of particle size on the identification of the sentinel node in cutaneous malignancies. Ann Surg Oncol 1998;5:77-80.
12. Glass EC, Essner R, Morton DL. Kinetics of three lymphoscintigraphic agents in patients with cutaneous melanoma. J Nucl Med 1998;39:1185-90.
13. Bedrosian I, Scheff AM, Mick R, et al. Technetium-99m human serum albumin: an effective radiotracer for identifying sentinel lymph nodes in melanoma. J Nucl Med 1999;40:1143-8.
14. Tafra L, Chua AN, Ng PC, Aycock D, Swanson M, Lannin D. Filtered versus unfiltered technetium sulfur colloid in lymphatic mapping: a significant variable in a pig model. Ann Surg Oncol 1999;6:83-7.
15. Czerniecki BJ, Carter C, Rivoltini L, et al. Calcium ionophore-treated peripheral blood monocytes and dendritic cells rapidly display characteristics of activated dendritic cells. J Immunol 1997; 159:3823-37.
16. Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J Exp Med 1994;179:1109-18.
17. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
18. O'Hea BJ, Hill DK, El-Shirbiny AM, et al. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center. J Am Coll Surg 1998;186:423-7.
19. Goydos JS, Ravikumar TS, Gerimino J, Yudd A, Bancila E. Minimally invasive staging of patients with melanoma: sentinel lymphadenectomy and detection of the melanoma-specific proteins Mart-1 and tyrosinase by reverse transcriptase polymerase chain reaction. J Am Coll Surg 1998;187:182-8.
20. Krag DN, Meijer SJ, Weaver DL, et al. Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995;130:654-8.
21. Borgstein PJ, Pijpers R, Comans EF, van Diest PJ, Boom RP, Meijer S. Sentinel lymph node biopsy in breast cancer: guidelines and pitfalls of lymphoscintigraphy and gamma probe detection. J Am Coll Surg 1998;186:275-83.
22. Ikomi F, Hanna GK, Schmid-Schonbein GW. Mechanism of colloidal particel uptake into the lymphatic system: basic study with percutaneous lymphography. Radiology 1995;196:107-13.
23. Picker LJ, Siegelman MH. Lymphoid tissues and organs. In: Paul WE, ed. Fundamental Immunology. New York: Raven Press, 1993: 145-97.
24. Hill ADK, Tran KN, Akhurst T, et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 1999;229: 528-35.